HCW Biologics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AVANTAX PLANNING PARTNERS, INC. | 04/29/2025 | 279.54 K | $78.86 K | 0.00% | 0.02% |
| VANGUARD GROUP INC | 05/09/2025 | 243.16 K | $68.57 K | 545.38% | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 236.97 K | $66.86 K | 30.23% | 0.01% |
| CRESSET ASSET MANAGEMENT, LLC | 05/13/2025 | 131.99 K | $37.23 K | 0.00% | 0.01% |
| PULLEN INVESTMENT MANAGEMENT, LLC | 04/16/2025 | 75.12 K | $21.19 K | 0.00% | 0.00% |
| J.W. COLE ADVISORS, INC. | 05/05/2025 | 53.40 K | $15.07 K | 100.00% | 0.00% |
| BLACKROCK, INC. | 05/02/2025 | 42.18 K | $11.90 K | -1.88% | 0.00% |
| AE WEALTH MANAGEMENT LLC | 05/06/2025 | 30.00 K | $8.46 K | 0.00% | 0.00% |
| STATE STREET CORP | 05/15/2025 | 21.45 K | $6.05 K | 0.00% | 0.00% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 05/14/2025 | 16.26 K | $4.59 K | 100.00% | 0.00% |
| CITIGROUP INC | 05/12/2025 | 14.05 K | $3.96 K | 100.00% | 0.00% |
| NORTHERN TRUST CORP | 05/13/2025 | 10.21 K | $2.88 K | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 1.01 K | $285 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 210 | $59 | 43.84% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 32 | $9 | -98.21% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| HIGHTOWER ADVISORS, LLC | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
HCW Biologics Inc. institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of HCW Biologics Inc.. The most heavily invested institutionals were:
Avantax Planning Partners, Inc.: 279,541
VANGUARD GROUP INC: 243,158
GEODE CAPITAL MANAGEMENT, LLC: 236,967
Cresset Asset Management, LLC: 131,990
Pullen Investment Management, LLC: 75,116
J.W. COLE ADVISORS, INC.: 53,402
0.06% of HCW Biologics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.20 M shares in the last 24 months. This purchase volume represents approximately $4.86 M in transactions.